Shel Liang is a strategic and visionary leader in global oncology, presently serving as the Global Medical Director for Prostate Cancer at Pfizer. With a Doctor of Philosophy degree from Penn State University, Shel has held various significant roles in the medical affairs space, including Medical Director for US Medical Affairs in Prostate Cancer at Pfizer and Director of Personalized Medicine at Sarah Cannon Research Institute. Their extensive experience also includes positions at EMD Serono, Abbott Molecular, Eisai US, and AbbVie, focusing on precision medicine, molecular diagnostics, and lifecycle strategy in oncology. Additionally, Shel contributed to the field as a Scientist II specializing in Biochemistry and Cellular Pharmacology at EMD Serono.
This person is not in any teams
This person is not in any offices